InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: patientlywaiting post# 178311

Sunday, 06/01/2014 4:57:26 PM

Sunday, June 01, 2014 4:57:26 PM

Post# of 346050
Some new names popping out for the "SunRise" Trial.... I am hoping http://www.theanswertocancer.org Day #2 Lung Cancer has a little Bavi to the story.

David E. Gerber 1,
1. The University of Texas Southwestern Medical Center, Dallas, TX;

Joseph Shan 2,
2. Peregrine Pharmaceuticals, Inc., Tustin, CA;

Ulrich Keilholz 3,
3. Charité Comprehensive Cancer Center, Berlin, Germany;

David R. Spigel 4,
4. Sarah Cannon Research Institute, Nashville, TN;

Leora Horn 5,
5. Vanderbilt-Ingram Cancer Center, Nashville, TN;

Rebecca Suk Heist 6,
6. Massachusetts General Hospital, Boston, MA;

Rachel E. Sanborn 7,
7. Providence Portland Medical Center, Portland, OR;

Paul N. Mainwaring 8,
8. ICON Cancer Care, South Brisbane, Australia;

Chandra Prakash Belani 9,
9. Penn State Hershey Cancer Institute, Hershey, PA;

Martin J. Edelman 10;
10. University of New Mexico Cancer Center, Albuquerque, NM

http://www.peregrineinc.com/images/stories/pdfs/sunrise_2014.pdf

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News